Subtype
Intermediate Soft Tissue Neoplasm
CI-CAN-00001021Explore in graph →
Non-malignant32 active trials42 evidence items
- NCIt
- C7653
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001021Explore in graph →
Clinical trials
136 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07661342 | DEPART Study at Yale(Dupuytren's) | not yet recruiting | Phase 3 | 158 | Yale UniversityOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT07656909 | Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP | recruiting | Phase 2 / Phase 3 | 76 | Yi JiOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT04871282 |
| A Study of AL102 in Patients With Progressing Desmoid Tumors(RINGSIDE) |
| active not recruiting |
| Phase 2 / Phase 3 |
| 198 |
| Immunome, Inc.INDUSTRY |
| 11 |
| Jun 8, 2026 |
| clinicaltrials |
| NCT03507010 | Ledderhose Disease: Radiotherapy or Not?(LedRad) | active not recruiting | Phase 3 | 84 | University Medical Center GroningenOTHER | 1 | Feb 28, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jun 22, 2026source: clinicaltrials